BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 11, Issue 8
This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (6564)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-5) series.
Item 
Count 
PDF436
WORD171
HTML3109
Figures (1-1)225
Tables (1-5)213
 Sum=4154
Featured Article
The chart showing Browse series, Download series.
Item 
Count 
Browse308
Download692
 Sum=1000
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse496
Download914
 Sum=1410
Aug 19, 2021 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Psychiatry
ISSN
2220-3206
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Duan C, Jenkins ZM, Castle D. Therapeutic use of melatonin in schizophrenia: A systematic review. World J Psychiatr 2021; 11(8): 463-476 [PMID: 34513608 DOI: 10.5498/wjp.v11.i8.463]
URL: https://www.wjgnet.com/1007-9327/full/v11/i8/463.htm
Number Citing Articles
1
Daniel P. Cardinali, Seithikurippu R. Pandi-Perumal, Gregory M. Brown. Sleep and Clocks in Aging and Longevity. Healthy Ageing and Longevity 2023; 18: 277 doi: 10.1007/978-3-031-22468-3_14
2
Reut Hazani, Michal Lavidor, Aron Weller. Treatments for Social Interaction Impairment in Animal Models of Schizophrenia: A Critical Review and Meta-analysis. Schizophrenia Bulletin 2022; 48(6): 1179 doi: 10.1093/schbul/sbac093
3
Muhammad Naveed, Owen Y. Chao, Jennifer W. Hill, Yi-Mei Yang, Joseph P. Huston, Ruifeng Cao. Circadian neurogenetics and its implications in neurophysiology, behavior, and chronomedicine. Neuroscience & Biobehavioral Reviews 2024; 157: 105523 doi: 10.1016/j.neubiorev.2023.105523
4
Eunsoo Moon, Kyungwon Kim, Timo Partonen, Outi Linnaranta. Role of Melatonin in the Management of Sleep and Circadian Disorders in the Context of Psychiatric Illness. Current Psychiatry Reports 2022; 24(11): 623 doi: 10.1007/s11920-022-01369-6
5
K. B. Megha, A. Arathi, Saini Shikha, Rao Alka, Prabhu Ramya, P. V. Mohanan. Significance of Melatonin in the Regulation of Circadian Rhythms and Disease Management. Molecular Neurobiology 2024;  doi: 10.1007/s12035-024-03915-0
6
Ying Zhu, Yuxi Yang, Gongang Ni, Shijin Li, Wei Liu, Zhongbao Gao, Xiao Zhang, Qi Zhang, Changyong Wang, Jin Zhou. On-demand electrically controlled melatonin release from PEDOT/SNP composite improves quality of chronic neural recording. Frontiers in Bioengineering and Biotechnology 2023; 11 doi: 10.3389/fbioe.2023.1284927
7
Ahmed Naguy. Therapeutic use of melatonin in schizophrenia-more than meets the eye!. World Journal of Psychiatry 2022; 12(3): 533-535 doi: 10.5498/wjp.v12.i3.533
8
Alexandre González-Rodríguez, José Haba-Rubio, Judith Usall, Mentxu Natividad, Virginia Soria, Javier Labad, José A. Monreal. Hormone Targets for the Treatment of Sleep Disorders in Postmenopausal Women with Schizophrenia: A Narrative Review. Clocks & Sleep 2022; 4(1): 52 doi: 10.3390/clockssleep4010007
9
Rodney R. Dietert, Janice M. Dietert. Using Microbiome-Based Approaches to Deprogram Chronic Disorders and Extend the Healthspan following Adverse Childhood Experiences. Microorganisms 2022; 10(2): 229 doi: 10.3390/microorganisms10020229
10
Elise Koch, Karolina Kauppi, Chi-Hua Chen. Candidates for drug repurposing to address the cognitive symptoms in schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2023; 120: 110637 doi: 10.1016/j.pnpbp.2022.110637
11
Yaiza Potes, Cristina Cachán-Vega, Eduardo Antuña, Claudia García-González, Nerea Menéndez-Coto, Jose Antonio Boga, José Gutiérrez-Rodríguez, Manuel Bermúdez, Verónica Sierra, Ignacio Vega-Naredo, Ana Coto-Montes, Beatriz Caballero. Benefits of the Neurogenic Potential of Melatonin for Treating Neurological and Neuropsychiatric Disorders. International Journal of Molecular Sciences 2023; 24(5): 4803 doi: 10.3390/ijms24054803
12
Jitendra Kumar Sinha, Punya Sachdeva, Faizan Ahmad, Jasmine Sarkar, Raafiah Izhar, Ayesha Rahman, Shampa Ghosh. Cognizance of Schizophrenia:: A Profound Insight into the Psyche. 2023; : 149 doi: 10.1007/978-981-19-7022-1_10
13
Tsutomu Takahashi, Stephen J. Wood, Alison R. Yung, Barnaby Nelson, Ashleigh Lin, Hok Pan Yuen, Lisa J. Phillips, Michio Suzuki, Patrick D. McGorry, Dennis Velakoulis, Christos Pantelis. Pineal morphology of the clinical high-risk state for psychosis and different psychotic disorders. Schizophrenia Research 2022; 244: 1 doi: 10.1016/j.schres.2022.04.005
14
Namra Aziz, Vipin Kumar Garg, Yadav Rupali Vinod, Arpit Gupta, Ankita Wal, Shruti Rathore, Pranay Wal. An Update on the Role of Circadian Rhythms in Sleep Disorders. Current Drug Therapy 2024; 19(3): 302 doi: 10.2174/1574885518666230818102714
15
Abdolhakim Ghanbarzehi, Ali Sepehrinezhad, Nazanin Hashemi, Minoo Karimi, Ali Shahbazi. Disclosing common biological signatures and predicting new therapeutic targets in schizophrenia and obsessive–compulsive disorder by integrated bioinformatics analysis. BMC Psychiatry 2023; 23(1) doi: 10.1186/s12888-023-04543-z
16
Shen-Chieh Chang, Kah Kheng Goh, Mong-Liang Lu. Metabolic disturbances associated with antipsychotic drug treatment in patients with schizophrenia: State-of-the-art and future perspectives. World Journal of Psychiatry 2021; 11(10): 696-710 doi: 10.5498/wjp.v11.i10.696
17
Satyam Chauhan, Andrei Barbanta, Ulrich Ettinger, Veena Kumari. Pineal Abnormalities in Psychosis and Mood Disorders: A Systematic Review. Brain Sciences 2023; 13(5): 827 doi: 10.3390/brainsci13050827
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345